Treatment for Trigger Thumb

Phase-Based Estimates
3
Effectiveness
3
Safety
University of Missouri Health Care, Columbia, MO
Trigger Thumb+2 More
Eligibility
18+
All Sexes
Eligible conditions
Trigger Thumb

Study Summary

This study is evaluating whether a steroid injection is the best treatment for trigger finger.

See full description

Eligible Conditions

  • Trigger Thumb
  • Trigger Finger Disorder
  • Tenosynovitis
  • Trigger Finger

Treatment Effectiveness

Effectiveness Estimate

3 of 3
This is better than 93% of similar trials

Study Objectives

This trial is evaluating whether Treatment will improve 4 primary outcomes in patients with Trigger Thumb. Measurement will happen over the course of 12 Weeks.

12 Weeks
Green classification of trigger finger severity
6 Month
Disabilities of the Arm, Shoulder and Hand (DASH)
Pain Visual Analog Score (VAS)
Upper Extremity Scores (PROMIS)

Trial Safety

Safety Estimate

3 of 3
This is better than 85% of similar trials

Trial Design

3 Treatment Groups

Triamcinolone 10mg/mL

This trial requires 200 total participants across 3 different treatment groups

This trial involves 3 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 4 and have been shown to be safe and effective in humans.

Triamcinolone 10mg/mL
Drug
A corticosteroid injection of Triamcinolone 10mg/mL will be given to subjects to treat their symptoms of trigger finger.
Soluble dexamethasone 4mg/mL
Drug
A corticosteroid injection of Soluble Dexamethasone 4mg/mL will be given to subjects to treat their symptoms of trigger finger.
Triamcinolone 40mg/mL
Drug
A corticosteroid injection of Triamcinolone 40mg/mL will be given to subjects to treat their symptoms of trigger finger.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 month
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 6 month for reporting.

Who is running the study

Principal Investigator
J. T. B.
Prof. Jay T. Bridgeman, MD
University of Missouri-Columbia

Closest Location

University of Missouri Health Care - Columbia, MO

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 3 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Patients recommended to receive corticosteroid injections
At least one symptomatic trigger finger
Adults aged 18 years and older

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Trigger Thumb by sharing your contact details with the study coordinator.